Sign up to save your podcasts
Or
Share The PR Week Live: Healthcare Conference Special with Sally Susman and Richard Edelman
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The PR Week Live: Healthcare Conference Special with Sally Susman and Richard Edelman
Wednesday’s PRWeek Healthcare Conference + Awards in New York marked a new milestone for the brand: its first-ever live podcast — and it has guests worthy of the occasion.
PRWeek editorial director Steve Barrett was joined on stage by Sally Susman, EVP and chief corporate affairs officer at Pfizer, who discussed her experiences working on communications during the COVID-19 vaccine, batting away disinformation and why comms is more of a hard skill than a soft skill.
Joining Susman was Edelman CEO Richard Edelman, who discussed building healthcare expertise at an agency, winning over skeptics on issues such as vaccines and working with controversial clients.
Plus a conversation between the two industry heavyweights on building consensus and taking on controversial political and social issues.
Follow us on Twitter: @PRWeekUS
Receive the latest industry news, insights, and special reports. Start Your Free 1-Month Trial Subscription To PRWeek
Follow us: @PRWeekUS
Receive the latest industry news, insights, and special reports. Start Your Free 1-Month Trial Subscription To PRWeek
View all episodes
By Steve Barrett, PRWeek
4.6
1313 ratings
Wednesday’s PRWeek Healthcare Conference + Awards in New York marked a new milestone for the brand: its first-ever live podcast — and it has guests worthy of the occasion.
PRWeek editorial director Steve Barrett was joined on stage by Sally Susman, EVP and chief corporate affairs officer at Pfizer, who discussed her experiences working on communications during the COVID-19 vaccine, batting away disinformation and why comms is more of a hard skill than a soft skill.
Joining Susman was Edelman CEO Richard Edelman, who discussed building healthcare expertise at an agency, winning over skeptics on issues such as vaccines and working with controversial clients.
Plus a conversation between the two industry heavyweights on building consensus and taking on controversial political and social issues.
Follow us on Twitter: @PRWeekUS
Receive the latest industry news, insights, and special reports. Start Your Free 1-Month Trial Subscription To PRWeek
Follow us: @PRWeekUS
Receive the latest industry news, insights, and special reports. Start Your Free 1-Month Trial Subscription To PRWeek